Skip to Main Content

Author Details

Benilton S Carvalho
Brazilian Institute of Neuroscience and Neurotechnology (BRAINN)
2006
47
22
PMIDPaper TitleJournal TitlePublished Year
35238489Benchmarking the proteomic profile of animal models of mesial temporal epilepsy.Ann Clin Transl Neurol2022
35238489Benchmarking the proteomic profile of animal models of mesial temporal epilepsy.Ann Clin Transl Neurol2022
33037862Multi-omics analysis suggests enhanced epileptogenesis in the Cornu Ammonis 3 of the pilocarpine model of mesial temporal lobe epilepsy.Hippocampus2021
33595142Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia - The SPASTOX Trial.Mov Disord2021
33037862Multi-omics analysis suggests enhanced epileptogenesis in the Cornu Ammonis 3 of the pilocarpine model of mesial temporal lobe epilepsy.Hippocampus2021
34529350Molecular diagnosis in a cohort of 114 patients with rare skeletal dysplasias.Am J Med Genet C Semin Med Genet2021
33595142Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia - The SPASTOX Trial.Mov Disord2021
34529350Molecular diagnosis in a cohort of 114 patients with rare skeletal dysplasias.Am J Med Genet C Semin Med Genet2021
32157145Laser microdissection-based microproteomics of the hippocampus of a rat epilepsy model reveals regional differences in protein abundances.Sci Rep2020
32424199Circulating lymphocytes and monocytes transcriptomic analysis of patients with type 2 diabetes mellitus, dyslipidemia and periodontitis.Sci Rep2020
32343762Methodological differences can affect sequencing depth with a possible impact on the accuracy of genetic diagnosis.Genet Mol Biol2020
32157145Laser microdissection-based microproteomics of the hippocampus of a rat epilepsy model reveals regional differences in protein abundances.Sci Rep2020
32464195Blood plasma proteomic modulation induced by olanzapine and risperidone in schizophrenia patients.J Proteomics2020
33046743Role of a genetic variation in the microRNA-4421 binding site of ERP29 regarding risk of oropharynx cancer and prognosis.Sci Rep2020
32699307Inherited variations in human pigmentation-related genes modulate cutaneous melanoma risk and clinicopathological features in Brazilian population.Sci Rep2020
33083011The Brazilian Initiative on Precision Medicine (BIPMed): fostering genomic data-sharing of underrepresented populations.NPJ Genom Med2020
32780732Identification of common and divergent gene expression signatures in patients with venous and arterial thrombosis using data from public repositories.PLoS One2020
33083011The Brazilian Initiative on Precision Medicine (BIPMed): fostering genomic data-sharing of underrepresented populations.NPJ Genom Med2020
33046743Role of a genetic variation in the microRNA-4421 binding site of ERP29 regarding risk of oropharynx cancer and prognosis.Sci Rep2020
32699307Inherited variations in human pigmentation-related genes modulate cutaneous melanoma risk and clinicopathological features in Brazilian population.Sci Rep2020
32780732Identification of common and divergent gene expression signatures in patients with venous and arterial thrombosis using data from public repositories.PLoS One2020
32464195Blood plasma proteomic modulation induced by olanzapine and risperidone in schizophrenia patients.J Proteomics2020
32343762Methodological differences can affect sequencing depth with a possible impact on the accuracy of genetic diagnosis.Genet Mol Biol2020
32424199Circulating lymphocytes and monocytes transcriptomic analysis of patients with type 2 diabetes mellitus, dyslipidemia and periodontitis.Sci Rep2020
31001185Multimodal Analysis of <i>SCN1A</i> Missense Variants Improves Interpretation of Clinically Relevant Variants in Dravet Syndrome.Front Neurol2019
31554886Distribution of local ancestry and evidence of adaptation in admixed populations.Sci Rep2019
31001185Multimodal Analysis of <i>SCN1A</i> Missense Variants Improves Interpretation of Clinically Relevant Variants in Dravet Syndrome.Front Neurol2019
31554886Distribution of local ancestry and evidence of adaptation in admixed populations.Sci Rep2019
29461643Dysregulation of NEUROG2 plays a key role in focal cortical dysplasia.Ann Neurol2018
30096301Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.Cell2018
29461643Dysregulation of NEUROG2 plays a key role in focal cortical dysplasia.Ann Neurol2018
30096301Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.Cell2018
28052106A Prediction Algorithm for Drug Response in Patients with Mesial Temporal Lobe Epilepsy Based on Clinical and Genetic Information.PLoS One2017
28817650snoRNA and piRNA expression levels modified by tobacco use in women with lung adenocarcinoma.PLoS One2017
28384161MicroRNA hsa-miR-134 is a circulating biomarker for mesial temporal lobe epilepsy.PLoS One2017
28988769Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.Cell2017
28052106A Prediction Algorithm for Drug Response in Patients with Mesial Temporal Lobe Epilepsy Based on Clinical and Genetic Information.PLoS One2017
28384161MicroRNA hsa-miR-134 is a circulating biomarker for mesial temporal lobe epilepsy.PLoS One2017
28988769Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.Cell2017
28817650snoRNA and piRNA expression levels modified by tobacco use in women with lung adenocarcinoma.PLoS One2017
27008013Working with Oligonucleotide Arrays.Methods Mol Biol2016
26935982RNA sequencing reveals region-specific molecular mechanisms associated with epileptogenesis in a model of classical hippocampal sclerosis.Sci Rep2016
27008013Working with Oligonucleotide Arrays.Methods Mol Biol2016
27895618Cyclooxygenase-1 as a Potential Therapeutic Target for Seizure Suppression: Evidences from Zebrafish Pentylenetetrazole-Seizure Model.Front Neurol2016
27538595MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis.J Neurol Sci2016
27895618Cyclooxygenase-1 as a Potential Therapeutic Target for Seizure Suppression: Evidences from Zebrafish Pentylenetetrazole-Seizure Model.Front Neurol2016
27538595MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis.J Neurol Sci2016
26935982RNA sequencing reveals region-specific molecular mechanisms associated with epileptogenesis in a model of classical hippocampal sclerosis.Sci Rep2016
25633503Orchestrating high-throughput genomic analysis with Bioconductor.Nat Methods2015
25633503Orchestrating high-throughput genomic analysis with Bioconductor.Nat Methods2015
  • 1 - 50 of 94

Recommended Authors

Roswell Park Cancer Institute, University of Buffalo
Career Start Year 2010
Number of shared co-authors 5
Ontario Institute for Cancer Research
Career Start Year 2009
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 2009
Number of shared co-authors 5
Departments of Bioinformatics and Clinical Genomics, Illumina Inc.
Career Start Year 2009
Number of shared co-authors 0
Columbia University Irving Medical Center
Career Start Year 2009
Number of shared co-authors 0
Centre de Recherche du CHU de Quebec-Universite, Universite Laval
Career Start Year 2005
Number of shared co-authors 3
University of California San Diego Health System
Career Start Year 2004
Number of shared co-authors 4
University of Southern California
Career Start Year 2004
Number of shared co-authors 1
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2004
Number of shared co-authors 0
Boston Children's Hospital, Seoul National University, Seoul National University Hospital
Career Start Year 2003
Number of shared co-authors 0
Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital
Career Start Year 2003
Number of shared co-authors 0
Institute for Quantitative Health Science and Engineering, Michigan State University
Career Start Year 2002
Number of shared co-authors 3
Emory University
Career Start Year 2002
Number of shared co-authors 4
University of Pittsburgh School of Public Health
Career Start Year 2001
Number of shared co-authors 0
University of Pennsylvania
Career Start Year 2001
Number of shared co-authors 0
Virginia Commonwealth University
Career Start Year 2001
Number of shared co-authors 1
Amsterdam University Medical Centers (Amsterdam UMC)
Career Start Year 2001
Number of shared co-authors 2
Uppsala University
Career Start Year 2001
Number of shared co-authors 2
HudsonAlpha Institute for Biotechnology
Career Start Year 1999
Number of shared co-authors 2
Center for Spatial and Functional Genomics, Children's Hospital of Philadelphia
Career Start Year 1999
Number of shared co-authors 0
Perelman School of Medicine, University of Pennsylvania Philadelphia
Career Start Year 1999
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 1998
Number of shared co-authors 5
Oregon Health & Science University, University of California Berkeley
Career Start Year 1997
Number of shared co-authors 2
William Harvey Research Institute, Queen Mary University of London
Career Start Year 1997
Number of shared co-authors 4
Genomics and Translational Research Center
Career Start Year 1996
Number of shared co-authors 3
Yale University
Career Start Year 1995
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 0
Stanford University
Career Start Year 1991
Number of shared co-authors 1
Karolinska Institute
Career Start Year 1988
Number of shared co-authors 0
Nanfang Hospital and Basic Medical College, Southern Medical University
Career Start Year 1987
Number of shared co-authors 7

Collaborators

Dana-Farber Cancer Institute
Co-authored papers 14
Center for Health Data Science and Analytics
Co-authored papers 4
Co-authored papers 3
New York University Grossman School of Medicine
Co-authored papers 3
The University of Melbourne
Co-authored papers 3
University of Alabama at Birmingham
Co-authored papers 2
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers 2
National Institute of Environmental Health Sciences (NIEHS)
Co-authored papers 2
University of Texas MD Anderson Cancer Center
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Van Andel Institute
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Co-authored papers 2
Nationwide Children's Hospital
Co-authored papers 2
Broad Institute
Co-authored papers 2
National Institute of Environmental Health Sciences (NIEHS)
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
University of Campinas (UNICAMP)
Co-authored papers 2
Johns Hopkins School of Medicine
Co-authored papers 2
Kennedy Krieger Institute, Johns Hopkins University School of Medicine
Co-authored papers 2
Federal University of Parana
Co-authored papers 2
Irving Institute for Cancer Dynamics, Columbia University
Co-authored papers 2
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 2
Co-authored papers 2
Fred Hutchinson Cancer Center
Co-authored papers 2
Broad Institute
Co-authored papers 2
Co-authored papers 2
Present address: Dxige Research Inc.
Co-authored papers 2